Abstract
We would like to thank Dr. Margonis and colleagues for their response to our article and considerate comments. Our study had demonstrated that indeterminate extrahepatic disease in the lungs, as identified by 2-[18F]fluoro-2-deoxy-D-glucose positron emission tomography had a predictive value in identifying patients at risk for site-specific recurrence.1 In their response, Margonis and colleagues had proposed the integration of Kirsten Rat Sarcoma (KRAS) mutation status to improve the prognostic impact of indeterminate colorectal lung metastases in patients being considered for resection of colorectal liver metastasis.
Original language | English |
---|---|
Pages (from-to) | e9-e10 |
Number of pages | 2 |
Journal | Annals of Surgery |
Volume | 268 |
Issue number | 1 |
DOIs | |
Publication status | Published - 1 Jul 2018 |